Skip to main content
OpenTrials

Clinical trial condition

Uterine Diseases

Explore clinical trials studying Uterine Diseases. Study availability and eligibility vary by location and protocol.

3,039 public trials 691 recruiting studies
Refine in advanced search Browse all conditions

Uterine Diseases trial results

Active, Not Recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details
Active, Not Recruiting

A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

NCT06533059

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Cancer, +36 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Sarasota, Florida, United States
  • Research Site Boston, Massachusetts, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

NCT05787587

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Cancer, +44 more
Locations
  • HonorHealth Research Institute Phoenix, Arizona, United States
  • The Angeles Clinic Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • California Pacific Medical Center San Francisco, California, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer

NCT05634499

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Mount Sinai Medical Center Miami Beach, Florida, United States
  • Minnesota Oncology Minneapolis Minneapolis, Minnesota, United States
  • Englewood Health/Hematology Oncology Practice of Englewood (HOPE) Englewood, New Jersey, United States
View Trial Details
Active, Not Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)

NCT06611540

Conditions
Cervical Carcinoma, Communicable Diseases, DNA Virus Infections, +23 more
Locations
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • UofL Health Medical Center Northeast Louisville, Kentucky, United States
  • University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
  • Minneapolis VA Medical Center Minneapolis, Minnesota, United States
View Trial Details
Active, Not Recruiting

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)

NCT06611553

Conditions
Cervical Carcinoma, Communicable Diseases, DNA Virus Infections, +23 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Yale University New Haven, Connecticut, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Louisiana State University Health Science Center New Orleans, Louisiana, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation

NCT07023731

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +61 more
Locations
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Tampa, Florida, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

NCT02257528

Conditions
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Female Urogenital Diseases, +16 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 332 locations
View Trial Details

Related conditions